|
MechanismCav2.1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date01 Jan 1992 |
100 Clinical Results associated with Japan Established Medicine Corp
0 Patents (Medical) associated with Japan Established Medicine Corp
100 Deals associated with Japan Established Medicine Corp
100 Translational Medicine associated with Japan Established Medicine Corp